Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",19548,137,1.60 [1.18-2.17],0.0027098598431788
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",20392,154,1.58 [1.18-2.13],0.0022860996284723
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",20178,1169,1.41 [1.25-1.59],2.213064915118948e-08
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter I Certain infectious and parasitic diseases,Candidiasis,20402,309,1.44 [1.15-1.81],0.0017376679107659
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,19796,2893,1.29 [1.19-1.40],1.6872929716721575e-09
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),19792,2930,1.38 [1.27-1.49],1.0157568003471784e-15
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,20221,877,1.15 [0.97-1.35],0.1044507243626297
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,20345,68,1.50 [0.94-2.37],0.0863132054439005
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,18512,909,1.66 [1.47-1.86],7.623545195982763e-17
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,17846,997,1.56 [1.39-1.76],3.102410589435834e-13
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,17667,205,1.52 [1.16-1.99],0.00249999463227
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,14358,1904,1.36 [1.23-1.51],1.727637429727659e-09
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,17607,336,1.76 [1.47-2.11],1.1092522705062855e-09
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,20393,1049,1.23 [1.06-1.42],0.0051900242274839
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter I Certain infectious and parasitic diseases,Mycoses,20479,386,1.42 [1.15-1.74],0.0008884204391431
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,19742,733,1.54 [1.34-1.77],1.4575872842413827e-09
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,20413,1002,1.59 [1.42-1.78],1.948245992825139e-15
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,19500,156,1.53 [1.13-2.08],0.0055874784739225
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,20513,42,1.80 [1.10-2.94],0.0193509223567685
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter I Certain infectious and parasitic diseases,Other septicaemia,20285,874,1.62 [1.44-1.83],4.068740537643179e-15
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,20331,54,1.46 [0.84-2.56],0.1788583626438863
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter I Certain infectious and parasitic diseases,Other viral diseases,20452,101,2.14 [1.67-2.73],1.239335863086485e-09
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",20437,86,2.00 [1.50-2.67],2.099930740420449e-06
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,19411,402,1.44 [1.18-1.75],0.0003586782018365
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,19248,239,1.46 [1.13-1.89],0.0037659598772159
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,19414,70,2.20 [1.64-2.96],1.846014909454373e-07
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,20494,59,1.56 [0.95-2.55],0.0759565586890907
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,20463,127,1.31 [0.89-1.92],0.1780077945750629
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter I Certain infectious and parasitic diseases,Viral warts,20383,47,0.84 [0.36-1.97],0.6916793860392108
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],20382,46,1.36 [0.74-2.51],0.3199840616561654
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,Benign lipomatous neoplasm,20246,302,0.62 [0.42-0.91],0.0137823467807252
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,20454,43,0.70 [0.27-1.86],0.4791795712207822
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,20418,50,0.60 [0.24-1.55],0.2942345160525653
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,20474,108,0.69 [0.37-1.28],0.241164949505037
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",20191,1410,0.93 [0.80-1.08],0.354315519577268
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,Benign neoplasm of meninges,20512,27,0.58 [0.16-2.13],0.4091881821884566
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,20460,60,1.86 [1.26-2.75],0.0017100369125687
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,20499,66,1.27 [0.73-2.20],0.4060871416139392
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,Benign neoplasm: Ascending colon,20490,390,1.03 [0.79-1.34],0.822495134670795
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,Benign neoplasm: Caecum,20493,293,1.14 [0.86-1.52],0.3659926882806009
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",20401,66,0.70 [0.32-1.52],0.3633559596116295
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,Benign neoplasm: Descending colon,20486,246,1.04 [0.75-1.45],0.7959626316528673
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,Benign neoplasm: Rectum,20448,362,1.05 [0.80-1.38],0.733205204522918
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,20408,633,0.87 [0.69-1.09],0.2262559697173122
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,Benign neoplasm: Transverse colon,20476,477,1.06 [0.84-1.35],0.6109772280790309
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",15980,64,2.24 [1.12-4.46],0.0223803366608055
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",15978,62,1.37 [0.80-2.36],0.2541722824810063
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",20484,80,1.45 [0.93-2.26],0.1018635769723656
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,"Haemangioma, any site",20484,77,1.48 [0.95-2.31],0.0795850941001901
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,Lung cancer and mesothelioma,13671,307,1.70 [1.34-2.16],1.1007644153675602e-05
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,Lymphoid leukaemia,15974,58,24.46 [0.00-20121470.15],0.6454517051643108
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",16084,168,1.27 [0.89-1.82],0.1834728421052036
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",16161,245,1.36 [1.03-1.79],0.0303655530552279
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",15997,81,1.45 [0.92-2.28],0.1059117135914451
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",16031,115,1.21 [0.77-1.89],0.40437207418392
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",16044,128,1.16 [0.75-1.79],0.4982311646312873
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",15983,67,0.38 [0.15-0.94],0.0363790351035368
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",17098,1182,1.02 [0.87-1.19],0.7965014803018745
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",16045,129,0.97 [0.59-1.58],0.9006221315765028
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",16010,94,0.84 [0.45-1.55],0.5747203708108066
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,16023,107,1.59 [1.11-2.29],0.0124833912818231
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,Melanocytic naevi,20410,149,1.00 [0.65-1.55],0.9854296520306836
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,Melanocytic naevi of trunk,20486,86,0.84 [0.45-1.57],0.5830769699568561
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,Melanoma in situ,15944,63,1.65 [1.06-2.58],0.0266108223770809
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",16005,89,1.41 [0.90-2.21],0.1357549691899675
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",16058,142,1.38 [0.96-1.99],0.0794850835558623
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",16113,197,1.33 [0.97-1.83],0.0803700718980833
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",16004,88,1.42 [0.90-2.23],0.1289665829392412
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,Other benign neoplasms of skin,20400,124,1.23 [0.81-1.87],0.3212627621429109
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",16939,1023,1.17 [1.00-1.36],0.0436098109766577
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",17001,1085,1.21 [1.05-1.40],0.0098361200990373
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,20282,258,1.88 [1.55-2.27],7.583106220565931e-11
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,19061,67,1.66 [1.08-2.57],0.0220114631927389
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,20081,57,1.25 [0.68-2.29],0.4814418640207686
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,20067,2321,1.34 [1.22-1.47],3.0226004914502877e-10
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,19468,53,1.33 [0.73-2.41],0.3506787351826393
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,20154,42,0.77 [0.30-1.98],0.5918810673238379
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,20218,1224,1.32 [1.16-1.50],1.5969086004521202e-05
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,20216,1222,1.32 [1.16-1.50],1.545871669668125e-05
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,19075,81,2.29 [1.77-2.98],5.055001054525119e-10
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,20323,908,1.31 [1.13-1.51],0.0003299093223573
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,20208,96,1.49 [1.01-2.21],0.0464578594483611
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,20086,62,1.72 [1.14-2.59],0.0092789247827414
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,20080,56,0.97 [0.47-2.03],0.9431226153042483
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,20368,256,1.49 [1.17-1.89],0.0012316837613821
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,20431,40,1.42 [0.73-2.75],0.2990544422102442
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",20320,208,1.54 [1.19-1.99],0.0009970723664588
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,19477,62,1.47 [0.91-2.38],0.1121480600975407
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,15181,308,1.72 [1.42-2.09],4.278434675879696e-08
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,18744,136,1.25 [0.84-1.86],0.2674555795804473
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,18772,164,1.52 [1.12-2.05],0.0071872534393282
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,14925,52,2.15 [1.50-3.06],2.5540441550963594e-05
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,19361,54,0.69 [0.29-1.65],0.4035915646095438
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,18707,186,1.35 [0.98-1.85],0.0651288864797424
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",20121,491,1.20 [0.97-1.48],0.0939224221092959
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,19829,199,0.92 [0.61-1.37],0.6641903497470952
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,19748,118,0.89 [0.52-1.50],0.660395121308853
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,20256,949,1.18 [1.01-1.38],0.035654894272687
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,17589,916,1.21 [1.04-1.42],0.0133843631592281
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",14936,63,1.44 [0.86-2.41],0.1663781250736494
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",19798,35,1.26 [0.58-2.78],0.5586515539123064
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,15099,226,1.45 [1.10-1.90],0.007715858089259
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,14935,62,1.78 [1.17-2.69],0.0065528641717999
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,18171,3298,1.14 [1.04-1.24],0.0034874248191473
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,15031,158,1.57 [1.17-2.11],0.0023790099446872
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,15349,476,1.39 [1.14-1.68],0.0010145285958708
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,20466,228,1.64 [1.30-2.06],2.815064395340389e-05
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,20309,71,2.20 [1.66-2.92],3.5841565829007174e-08
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,15005,132,1.39 [0.97-1.99],0.0745847373036875
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",14927,54,1.42 [0.81-2.50],0.2179522807480114
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,20360,597,1.30 [1.08-1.56],0.0048274622775086
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,15126,253,1.84 [1.50-2.24],2.792615420596673e-09
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,15166,293,1.74 [1.44-2.12],1.8360772284723536e-08
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",15493,620,1.09 [0.88-1.34],0.4192695148890945
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,14988,115,1.71 [1.25-2.34],0.0007891358212912
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,20303,65,2.32 [1.76-3.04],1.735850176123022e-09
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,15366,493,1.55 [1.30-1.85],8.557136759047464e-07
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,15217,344,1.34 [1.06-1.70],0.0162897196341934
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,18570,49,1.78 [1.10-2.88],0.018664980522468
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,19320,4447,1.21 [1.13-1.30],8.510280150942349e-08
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,19774,11,0.93 [0.56-1.55],0.7714078983831435
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,19784,21,1.07 [0.34-3.33],0.906308195530774
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,20372,1513,1.10 [0.97-1.25],0.1545804235097239
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",20369,1509,1.10 [0.96-1.25],0.1669425853592542
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,19775,12,2.25 [1.08-4.72],0.0313846609570719
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,20283,688,1.21 [1.01-1.44],0.0427261254389553
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",16239,1366,1.55 [1.40-1.72],1.1175195862086207e-16
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,20504,202,1.73 [1.38-2.18],2.7468578114056884e-06
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,19716,86,1.22 [0.74-2.03],0.4365311102844826
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,19660,65,1.33 [0.78-2.29],0.2983541998346638
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,19669,74,0.86 [0.44-1.69],0.6681879321267213
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",14932,59,1.41 [0.82-2.40],0.21025869699638
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,18124,145,1.62 [1.21-2.17],0.0010707271103087
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,2160,104,1.83 [1.24-2.72],0.0024812582901539
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,2300,272,1.36 [1.02-1.82],0.0340474647199203
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,18060,81,1.81 [1.30-2.52],0.0003966516032924
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,2116,60,2.63 [1.84-3.75],9.992107895474965e-08
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,19860,1881,1.23 [1.10-1.36],0.0001322069946428
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,19904,274,1.15 [0.86-1.54],0.3453033961510326
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,18723,202,1.40 [1.04-1.89],0.0252326859250692
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,15521,648,1.59 [1.38-1.83],2.2530714789016528e-10
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",20404,210,1.04 [0.73-1.49],0.823216047432741
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),19486,234,1.20 [0.88-1.64],0.2480540297934829
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Angina pectoris,18045,1266,1.25 [1.10-1.42],0.0007155413462233
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Aortic aneurysm,19584,332,1.15 [0.88-1.51],0.2922895175722389
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,19321,69,2.10 [1.51-2.91],8.79645135217834e-06
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",19447,195,1.57 [1.21-2.04],0.000682392913213
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,12011,1948,1.22 [1.09-1.37],0.0005037022531919
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,AV-block,16555,512,1.25 [1.03-1.52],0.0227511270269811
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",20453,440,1.10 [0.86-1.39],0.4583158408006861
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Cardiac arrest,10277,214,1.89 [1.48-2.41],3.119385144411684e-07
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Cardiomyopathy,16219,176,1.08 [0.74-1.58],0.6899183000280473
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",16136,93,1.16 [0.70-1.90],0.5677497664791509
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,20513,50,1.45 [0.84-2.51],0.1771437488228938
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Conduction disorders,17189,1146,1.33 [1.17-1.51],7.492035465375123e-06
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,19007,2249,1.23 [1.11-1.36],5.219636026900485e-05
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,17363,6723,1.15 [1.08-1.22],1.3724629161081358e-05
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,DVT of lower extremities,19459,231,1.05 [0.75-1.48],0.7623128932233143
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Endocarditis,16115,72,1.57 [1.04-2.35],0.0302180502594271
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,"Heart failure, strict",20244,1126,1.43 [1.27-1.62],3.463192770358752e-09
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Hypertension,18382,5842,1.12 [1.05-1.20],0.0004626919171041
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,"Hypertension, essential",18386,5846,1.13 [1.05-1.20],0.000397501209609
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,"Hypertension, portal",20311,98,1.74 [1.27-2.40],0.0006348258681616
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",12714,174,1.79 [1.41-2.27],1.99205523927204e-06
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,12644,104,2.55 [2.06-3.15],4.958954928144776e-18
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Hypotension,20388,1018,1.49 [1.32-1.68],1.4183760897245776e-10
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,19614,96,0.76 [0.40-1.43],0.3934420794142851
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",19130,2351,1.24 [1.12-1.36],1.4734463766506727e-05
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",20160,555,1.18 [0.97-1.44],0.1065868316993586
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Left bundle-branch block,16390,347,1.43 [1.16-1.76],0.0008938944155224
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,19914,911,1.14 [0.96-1.34],0.1262530163843657
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",17570,791,1.26 [1.06-1.48],0.0071563808653843
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",20376,195,1.18 [0.83-1.66],0.3575016441533092
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",20469,321,1.23 [0.95-1.59],0.1215083856770577
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Oesophageal varices,19284,56,1.75 [1.16-2.65],0.0078556596357342
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Other aneurysm,19330,78,1.32 [0.80-2.16],0.2753335326291704
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Other arrhythmias,16452,409,1.22 [0.97-1.53],0.091757137318617
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,19364,112,2.03 [1.56-2.65],1.8704785943172418e-07
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,19485,233,1.71 [1.38-2.13],1.2698991086364174e-06
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,16202,159,1.19 [0.82-1.73],0.3679010049376769
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Other disorders of veins,19304,76,1.81 [1.28-2.56],0.000863208235026
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,19270,42,2.16 [1.45-3.21],0.000144782608526
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,19191,78,1.11 [0.63-1.93],0.7215589197031602
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,19316,88,1.20 [0.73-1.98],0.4600742447834004
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,17097,1054,1.24 [1.08-1.42],0.0028052941845616
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,19425,55,1.57 [0.96-2.59],0.0729881784441976
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,19724,472,1.53 [1.28-1.82],2.7780606614555725e-06
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,19957,320,1.59 [1.30-1.95],6.905136573958813e-06
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",19664,551,1.04 [0.84-1.30],0.698545055735942
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,10376,313,1.46 [1.16-1.86],0.0015619033991568
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Peripheral artery disease,19644,435,1.55 [1.30-1.86],1.052644472200742e-06
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),19525,297,0.95 [0.69-1.31],0.7695518166435662
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Pulmonary embolism,20059,422,1.17 [0.93-1.48],0.1798792999577224
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,20458,601,1.18 [0.97-1.43],0.0999675612938619
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Right bundle-branch block,16446,403,1.45 [1.20-1.76],0.0001265925886127
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Secondary right heart disease,19956,319,1.59 [1.30-1.95],7.77285408980824e-06
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,19299,186,1.69 [1.32-2.15],2.333189648049427e-05
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",20147,629,1.13 [0.93-1.38],0.2119499886910862
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",20136,653,1.12 [0.92-1.36],0.2472803263285772
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,19599,38,0.50 [0.16-1.57],0.2341210550465998
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,19349,98,1.15 [0.70-1.88],0.5858330650329484
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Transient ischemic attack,19807,202,1.21 [0.87-1.68],0.2494373199224117
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,19266,263,1.12 [0.83-1.52],0.4472993602952707
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Varicose veins,19553,325,0.91 [0.66-1.24],0.5440583621090644
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,19268,62,1.11 [0.59-2.09],0.752800242318706
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter IX Diseases of the circulatory system,Venous thromboembolism,20301,658,1.03 [0.84-1.26],0.77734385409746
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",20335,426,1.25 [1.00-1.56],0.0497554653849184
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",17678,831,1.24 [1.06-1.45],0.0083534701686273
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter V Mental and behavioural disorders,Any mental disorder,19915,3068,1.18 [1.09-1.29],0.0001381749249559
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",20281,495,1.21 [0.98-1.50],0.0718576333661381
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",17829,982,1.18 [1.01-1.37],0.0357623804189115
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",16910,63,1.53 [0.94-2.48],0.0869795540708418
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter V Mental and behavioural disorders,Smoking dependency,19942,1322,1.31 [1.15-1.49],2.676779728384677e-05
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",18446,1599,1.26 [1.12-1.41],0.0001094064938969
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter V Mental and behavioural disorders,Vascular dementia,20124,124,1.10 [0.70-1.72],0.6721997316950724
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Alzheimer disease,20513,249,0.90 [0.63-1.29],0.571415529461017
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,"Alzheimer√ïs disease (Atypical or mixed), excluding more controls",13745,50,1.25 [0.67-2.35],0.4852560932471562
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Bell's palsy,19341,68,1.66 [1.09-2.51],0.0177431016850033
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,19566,293,1.13 [0.85-1.50],0.4000398285468581
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Cerebral cysts,20173,199,1.17 [0.83-1.65],0.3764307112071414
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,20438,291,1.50 [1.20-1.89],0.0004558672313443
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,20100,55,0.91 [0.43-1.94],0.811797824281223
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,20497,68,1.68 [1.12-2.53],0.0121430021667644
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",20051,77,1.06 [0.59-1.92],0.8437348454042295
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Epilepsy,19142,235,1.28 [0.95-1.72],0.1093221578524536
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,20060,1153,1.26 [1.10-1.43],0.000738221629489
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,20481,405,0.95 [0.72-1.24],0.6901195705619332
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Falls/tendency to fall,20041,1821,1.24 [1.12-1.38],6.102576942696242e-05
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Generalized epilepsy,20190,51,1.13 [0.56-2.29],0.7317717349049813
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Hemiplegia,20374,227,1.50 [1.16-1.94],0.0022267207132702
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Hydrocephalus,20021,47,0.69 [0.27-1.76],0.4375258289410358
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,20497,53,0.96 [0.45-2.06],0.9138810206700624
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,19293,20,0.88 [0.54-1.45],0.6206804769331715
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,19353,80,1.26 [0.76-2.08],0.3641944467237581
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Memory loss,19986,105,1.33 [0.88-2.02],0.1734234883717008
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Migraine,19071,164,1.37 [0.98-1.91],0.0670739757125028
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",20493,149,1.47 [1.05-2.04],0.0234504298019191
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Motor neuron disease,13848,141,1.21 [0.82-1.80],0.3365580936358271
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,20411,59,1.18 [0.62-2.21],0.6178652449883073
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",20099,826,1.10 [0.93-1.31],0.2639136269281831
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Neurological diseases,19378,3020,1.13 [1.04-1.24],0.0054815103971224
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,20233,188,1.22 [0.87-1.72],0.2488894030768358
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",19588,315,1.04 [0.78-1.39],0.8005588027445631
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",20434,298,1.49 [1.19-1.86],0.0004406601528663
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,16205,518,1.16 [0.94-1.43],0.180046671381377
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,20038,64,1.07 [0.57-2.02],0.8291202027519322
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Other disorders of nervous system,20103,129,1.13 [0.73-1.73],0.5884033678725662
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,20188,112,0.83 [0.48-1.46],0.5276023535576044
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Other facial nerve disorders,19358,85,1.47 [0.96-2.25],0.0740591634521583
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Other headache syndromes,18941,34,1.41 [0.70-2.87],0.3393595462196173
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Other neurological diseases,20414,440,1.13 [0.90-1.43],0.2951949118407393
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Other sleep disorders,19504,597,1.27 [1.06-1.51],0.0093799539363238
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Parkinson's disease,20492,274,0.93 [0.66-1.30],0.6710028630630493
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,19997,23,1.02 [0.34-3.10],0.9668214282093088
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Restless leg syndrome,20512,36,0.67 [0.23-1.96],0.4637959779503946
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Sleep apnoea,20261,539,1.30 [1.08-1.56],0.0054808563499259
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Small fibre neuropathy,20185,49,1.64 [0.99-2.70],0.0530785252819665
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,20496,162,1.32 [0.93-1.86],0.1171392359076385
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,19302,29,0.97 [0.35-2.70],0.9498328691695528
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,20513,252,0.93 [0.65-1.32],0.6764636780325431
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),20097,120,1.10 [0.70-1.73],0.6864415632550717
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,20059,73,1.23 [0.72-2.12],0.4461865103675703
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,20221,251,0.84 [0.58-1.22],0.3638442345502298
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,20358,253,1.53 [1.21-1.94],0.0004575336693503
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,19756,39,0.53 [0.17-1.60],0.2573934515385582
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,19772,55,1.35 [0.75-2.43],0.3129942886467303
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",20435,34,0.88 [0.33-2.37],0.8018984046949703
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,20324,104,1.15 [0.72-1.85],0.5507992656124239
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",2116,60,2.80 [1.99-3.93],3.156496337380921e-09
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,2582,109,1.70 [1.18-2.45],0.0043117468825679
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,20068,82,1.05 [0.59-1.87],0.8588125063743871
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,20325,856,1.19 [1.01-1.40],0.033161004127528
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",20246,529,0.98 [0.77-1.24],0.8381412418459
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,19834,117,1.14 [0.72-1.81],0.5673411426756978
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",20451,481,0.81 [0.61-1.06],0.1256670014740465
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,20511,56,0.83 [0.38-1.83],0.6472943380736977
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,20396,426,0.82 [0.61-1.10],0.1811780149485576
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",20481,261,1.05 [0.77-1.45],0.7460631666128894
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,20438,131,1.07 [0.68-1.68],0.7648265565766881
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,19783,66,1.25 [0.72-2.20],0.4272377903491811
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,19791,74,0.66 [0.31-1.41],0.2828724996177471
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,19751,34,1.36 [0.64-2.90],0.4226302890114608
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,20433,583,1.08 [0.88-1.34],0.4646365802034147
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,20018,168,1.08 [0.73-1.60],0.6906346406704501
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,19994,24,0.51 [0.12-2.15],0.3615979160317162
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,20300,80,0.90 [0.48-1.71],0.7527893870548852
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,20405,185,1.15 [0.80-1.64],0.4443647029582331
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,20117,147,0.76 [0.46-1.26],0.2889698518699414
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,20376,69,1.19 [0.67-2.12],0.5528922734580618
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,20229,379,1.15 [0.89-1.48],0.2759965256179976
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,20086,100,1.40 [0.93-2.11],0.1047368560357216
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,19361,1516,1.19 [1.05-1.34],0.0062841729340984
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,20382,162,1.20 [0.83-1.73],0.3418610764907036
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,20497,122,1.40 [0.96-2.03],0.0785969235155856
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,20082,365,0.99 [0.75-1.31],0.9384091992518008
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,20277,57,0.96 [0.47-1.98],0.9172952899938028
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,20501,46,0.59 [0.22-1.58],0.2959325515665247
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,19779,62,0.99 [0.49-1.97],0.9670402489390412
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,19846,129,1.13 [0.73-1.74],0.5924101757591507
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,19575,106,1.06 [0.64-1.75],0.8323302075753561
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,20010,40,0.97 [0.41-2.28],0.9430057821018176
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",19526,57,1.52 [0.90-2.54],0.1150297049748741
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,19894,44,0.49 [0.17-1.42],0.1878909496720915
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",20022,172,1.02 [0.68-1.53],0.930696132159668
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,19813,96,0.73 [0.38-1.39],0.3355585959223962
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,19575,106,1.11 [0.68-1.81],0.6847750388124094
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,19547,78,1.24 [0.74-2.08],0.4064674359767192
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,19076,1231,1.11 [0.97-1.28],0.1377425039820496
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,19765,48,1.35 [0.72-2.56],0.3513531841160963
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,20307,321,1.23 [0.95-1.59],0.1180196915878048
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,20044,58,1.37 [0.77-2.42],0.2819755406020999
USP28,Ubiquitin carboxyl-terminal hydrolase 28,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),20115,129,1.24 [0.82-1.86],0.3082411316065809
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,20353,50,1.31 [0.71-2.44],0.3911239517274238
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,20477,107,1.30 [0.85-2.00],0.2322778804001185
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,20397,99,1.05 [0.62-1.77],0.8631376941242809
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,20349,46,0.95 [0.42-2.15],0.9080751517742977
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VIII Diseases of the ear and mastoid process,M¬éni¬ère disease,20350,47,1.42 [0.79-2.55],0.2439142056377849
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,20427,801,1.29 [1.10-1.51],0.0017155115681094
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,20219,593,1.39 [1.17-1.65],0.000181706430757
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,19740,114,1.49 [1.03-2.15],0.033312932744609
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,19696,70,1.03 [0.54-1.96],0.932567866745
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Acute pharyngitis,20327,47,1.57 [0.90-2.76],0.1146915141090853
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,20439,159,1.60 [1.20-2.14],0.0014354438781021
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,20334,54,1.53 [0.92-2.55],0.0988917932277729
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,All influenza,18588,86,1.14 [0.67-1.95],0.621322535758237
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),18585,83,1.04 [0.58-1.86],0.9073905412003668
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Allergic asthma (mode),13456,92,0.88 [0.47-1.62],0.6755737691731571
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Allergic rhinitis,20424,240,0.86 [0.59-1.26],0.4514911716724233
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",14307,1240,1.25 [1.09-1.42],0.0009481824904544
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",14579,1215,1.28 [1.12-1.45],0.0002069109534921
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),20176,124,1.49 [1.05-2.12],0.0260706084827749
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",18578,76,1.29 [0.77-2.16],0.3267154325046413
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Bronchiectasis,17811,252,1.48 [1.16-1.89],0.0015281967675293
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",17596,37,1.49 [0.79-2.83],0.2223150433228744
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,19774,2215,1.26 [1.15-1.39],1.7689494318669484e-06
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",19254,69,0.85 [0.42-1.72],0.6492618982252543
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Chronic sinusitis,19318,133,1.02 [0.64-1.63],0.929265710020542
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",20325,1129,1.40 [1.24-1.58],1.1075555774460457e-07
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Deviated nasal septum,19312,127,1.30 [0.87-1.92],0.1982449041044075
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,18768,4513,1.26 [1.18-1.35],3.053397656541837e-11
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",19531,346,1.38 [1.10-1.73],0.0055021103958327
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Early onset COPD,19476,280,1.82 [1.51-2.21],6.167856207960639e-10
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Emphysema,17873,314,1.45 [1.16-1.82],0.0012194662449219
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,19695,307,1.63 [1.34-1.99],1.6374315041424317e-06
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Influenza and pneumonia,20297,1795,1.43 [1.30-1.58],1.7457094634402277e-13
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Interstitial lung disease,19717,329,1.62 [1.33-1.97],1.6371059703546152e-06
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Later onset COPD,19562,849,1.22 [1.04-1.43],0.0143327763983954
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,20496,338,1.51 [1.22-1.85],0.0001133003326792
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Nasal polyp,19315,130,1.06 [0.67-1.68],0.7881963824496604
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,20276,834,1.50 [1.31-1.72],4.9961410583706865e-09
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Other diseases of pleura,20268,1884,1.33 [1.20-1.47],2.3792741547462226e-08
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,19951,766,1.10 [0.92-1.33],0.291811953495748
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Other pleural conditions,18437,53,2.05 [1.43-2.93],8.149331637856821e-05
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,20417,402,1.68 [1.42-1.99],2.606836213857376e-09
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,20403,1196,1.35 [1.19-1.53],1.7074579583777129e-06
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Pleural effusion,19332,948,1.44 [1.26-1.63],3.8944796052293296e-08
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Pleural plaque,18616,232,1.50 [1.17-1.92],0.0012417250911147
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",20079,1577,1.45 [1.31-1.60],5.690795096200383e-13
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,20406,248,1.45 [1.13-1.88],0.0038561408378961
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Pneumothorax,18504,120,1.07 [0.67-1.72],0.7742070303681822
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Pollen allergy,20499,208,0.71 [0.46-1.11],0.130193920727514
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Pulmonary oedema,20074,59,1.67 [1.07-2.61],0.0245002151973199
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Respiratory insufficiency,13415,51,2.09 [1.38-3.17],0.0005060672873944
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,20259,817,1.51 [1.32-1.73],3.751308558854918e-09
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,19426,241,0.87 [0.59-1.26],0.4557075025893154
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Viral pneumonia,18732,230,1.33 [1.00-1.77],0.054022316084017
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",20195,196,1.36 [1.00-1.84],0.0482917883688154
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,8993,100,1.75 [1.24-2.48],0.0015165326705576
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,14373,75,1.64 [1.09-2.47],0.016748100136462
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Acute appendicitis,20400,125,0.92 [0.56-1.52],0.7493919637110901
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Acute gastritis,15532,73,0.94 [0.49-1.80],0.8516712336139489
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Acute pancreatitis,19354,177,0.96 [0.64-1.46],0.8589831192856003
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Acute peritonitis,20198,79,1.35 [0.84-2.17],0.2094054368883633
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Alcoholic liver disease,19736,97,1.93 [1.44-2.59],1.131564324335722e-05
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Barrett oesophagus,15905,446,1.10 [0.86-1.39],0.4462666573673278
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",19281,104,1.35 [0.89-2.05],0.1534177261620583
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",20162,104,1.33 [0.87-2.02],0.1844962436650372
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Cholecystitis,19364,187,1.21 [0.85-1.70],0.2854865563684349
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Cholelithiasis,19863,686,1.36 [1.16-1.60],0.0001599490501492
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Chronic gastritis,15680,221,0.97 [0.67-1.39],0.8486844947599017
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Chronic pancreatitis,19224,47,1.52 [0.87-2.64],0.1401064828707555
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",20334,121,1.73 [1.29-2.31],0.0002178273213286
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Coeliac disease,19102,77,1.80 [1.24-2.60],0.0018655367116875
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Collagenous colitis,19270,42,0.88 [0.36-2.14],0.775960279279835
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,20363,190,1.07 [0.74-1.56],0.7090608395007988
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Constipation,20371,1321,1.11 [0.97-1.27],0.1314035939983543
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Crohn disease,19307,79,0.55 [0.25-1.20],0.1345499274382267
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",20216,58,0.45 [0.17-1.15],0.0961791953123992
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Crohn's disease NAS,19294,66,0.40 [0.16-0.99],0.0484166902959157
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Dental caries,19967,191,1.39 [1.03-1.88],0.0335717887443703
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,17391,1660,1.12 [0.99-1.27],0.0647284428800485
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Diseases of appendix,20426,151,0.95 [0.61-1.49],0.8255454489197553
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Diseases of liver,20392,753,1.41 [1.22-1.63],5.634529394209977e-06
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",18788,3329,1.08 [0.99-1.18],0.0818151930106576
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",20203,427,1.27 [1.02-1.58],0.0356313323901554
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Diseases of peritoneum,20471,352,1.21 [0.94-1.55],0.1322758108667782
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,19866,90,0.89 [0.49-1.63],0.711446974983258
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Diseases of salivary glands,19752,50,0.83 [0.36-1.94],0.6713060725256748
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Diseases of the digestive system,20241,1216,1.38 [1.23-1.56],1.239899115747618e-07
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Diseases of tongue,19763,98,1.45 [0.97-2.17],0.0720587897474503
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",20212,1035,1.27 [1.11-1.46],0.0006653155301262
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,16923,2625,1.06 [0.96-1.18],0.2161414809583987
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Duodenal ulcer,15677,218,1.41 [1.07-1.85],0.0161385336482181
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",20407,168,1.37 [0.98-1.90],0.0637261958315863
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,20453,36,1.50 [0.76-2.96],0.2478459238006496
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,19779,140,1.66 [1.25-2.20],0.0004059546816721
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,14451,153,1.05 [0.69-1.61],0.8063020652750592
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Functional dyspepsia,15812,353,0.74 [0.53-1.03],0.0752408714968307
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Gastric ulcer,15774,315,1.03 [0.77-1.39],0.8311342546757484
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,17305,1846,1.01 [0.89-1.15],0.8395380680465366
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,15960,501,1.13 [0.90-1.40],0.2868595907115682
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,15699,6856,1.11 [1.04-1.18],0.0011422912726258
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,GI-bleeding,20031,1006,1.35 [1.18-1.54],1.4524393746355275e-05
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,19821,45,1.71 [1.04-2.80],0.0342533906224209
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,15106,1042,1.12 [0.96-1.31],0.1572411599191976
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",19710,71,2.03 [1.50-2.76],5.612092979021514e-06
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Hernia,18745,3014,1.10 [1.00-1.21],0.0409501987760915
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Impacted teeth,20456,35,1.51 [0.77-2.99],0.2327851011451371
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Impaction of intestines,14336,38,0.52 [0.17-1.59],0.252425546408728
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Inguinal hernia,17130,1399,1.08 [0.94-1.24],0.2913785201819521
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",15897,166,0.77 [0.47-1.25],0.293867699483455
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,14375,77,1.18 [0.68-2.04],0.5633977736378666
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Intestinal malabsorption,19114,89,1.70 [1.18-2.45],0.0041121548856499
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,14540,242,0.98 [0.69-1.39],0.8904675381695027
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,20476,320,1.43 [1.14-1.78],0.0016453486809481
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,19807,579,1.32 [1.10-1.58],0.0028581398474333
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,19990,762,1.18 [1.00-1.41],0.0554930974815458
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Oesophageal obstruction,15640,181,1.42 [1.04-1.92],0.0248775094642726
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Oesophagitis,15998,539,1.16 [0.94-1.43],0.1600122245467654
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,20465,94,1.59 [1.09-2.32],0.0152868348060351
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,15794,63,0.52 [0.21-1.28],0.1551640851386629
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,15546,1248,1.14 [0.99-1.31],0.0638462656132793
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,19397,220,1.09 [0.78-1.54],0.6162315232076404
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,19279,102,1.11 [0.68-1.82],0.6754508225249221
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Other diseases of intestine,15934,1636,1.14 [1.01-1.28],0.0388117735554221
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Other diseases of intestines,18959,4661,1.11 [1.03-1.19],0.0060837035806722
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,19734,155,1.39 [1.00-1.95],0.051843499778347
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Other diseases of liver,20240,601,1.38 [1.16-1.63],0.0002039975108938
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,16084,625,1.21 [1.00-1.46],0.0491106007531323
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Other diseases of pancreas,19295,118,1.34 [0.90-2.00],0.1454167328994317
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,20416,297,1.12 [0.84-1.49],0.4520481212832613
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,16133,674,1.32 [1.12-1.56],0.0010961722884803
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,20040,1015,1.36 [1.19-1.55],8.561480424393693e-06
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,19922,146,1.17 [0.78-1.75],0.4371227371680697
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,15651,1353,1.13 [0.99-1.29],0.0722560330272686
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),17054,1595,1.22 [1.09-1.37],0.0006839162962768
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,19721,82,1.22 [0.74-2.02],0.4377804764101589
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,19894,666,1.25 [1.05-1.50],0.0113662007011852
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",14596,298,1.14 [0.86-1.52],0.3569427751553654
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,20444,43,1.42 [0.74-2.73],0.2976850175890805
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,14704,406,1.24 [0.98-1.56],0.0710221241930274
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",19171,146,1.36 [0.96-1.93],0.085237128680754
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Recurring oral aphthae,20501,36,1.87 [1.13-3.10],0.0149698499345406
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,19782,86,1.57 [1.04-2.35],0.0313296452771356
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Toxic colitis,19268,40,1.10 [0.50-2.45],0.8069656743815041
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,15722,263,1.29 [0.98-1.69],0.0717142656787136
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Ulcerative colitis,19355,127,1.08 [0.68-1.70],0.7496423858368377
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",19333,105,1.00 [0.59-1.70],0.9988905662992156
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Umbilical hernia,16045,314,0.87 [0.63-1.21],0.4151119873204725
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,14434,136,1.23 [0.84-1.82],0.2915338982414699
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Ventral hernia,15954,223,1.25 [0.91-1.70],0.1653614078499944
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XI Diseases of the digestive system,Volvulus,14360,62,1.33 [0.76-2.34],0.3158795438328923
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,20457,273,1.44 [1.13-1.83],0.0033957907554426
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,20246,61,1.63 [1.05-2.54],0.0310374936289756
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,18835,80,1.51 [0.99-2.31],0.0574138230744953
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,19881,649,1.30 [1.10-1.55],0.0024450512895516
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",19408,176,1.32 [0.95-1.83],0.1014604052131457
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,19133,378,1.42 [1.15-1.74],0.0009062295055385
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,20260,229,1.21 [0.89-1.65],0.214750398712381
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,20429,398,1.11 [0.87-1.43],0.3915086225132598
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,20071,40,0.98 [0.42-2.29],0.963616684759634
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,19229,2696,1.20 [1.09-1.31],8.209835220964544e-05
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,20117,347,1.18 [0.91-1.53],0.2016389600642021
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,20017,247,1.15 [0.84-1.57],0.3944031092666529
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,20114,882,1.34 [1.16-1.55],5.619350779652135e-05
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",20503,25,1.17 [0.44-3.06],0.7542249262752704
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,18778,23,0.98 [0.31-3.09],0.9678452704893368
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,19822,52,1.26 [0.68-2.33],0.4595283853735425
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,20256,225,1.23 [0.90-1.67],0.1896609078424575
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,19171,416,1.20 [0.95-1.51],0.1222059903088112
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,18821,66,1.85 [1.27-2.70],0.0013284656170999
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,20455,70,1.62 [1.06-2.47],0.0266332737183328
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,19402,170,1.49 [1.11-2.01],0.0075421446298025
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,20366,181,0.93 [0.62-1.41],0.7447461448117789
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,20088,57,1.40 [0.81-2.40],0.2237130840008749
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,18809,54,1.09 [0.55-2.17],0.8058549605643903
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,20120,1365,1.30 [1.16-1.46],1.2235441451043373e-05
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",19207,452,1.23 [0.99-1.52],0.063704905636005
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,18824,69,1.79 [1.22-2.61],0.0026784654618291
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,20436,251,0.99 [0.70-1.39],0.9441468670562684
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,20077,46,1.41 [0.78-2.56],0.2570537668717632
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,20405,220,0.98 [0.68-1.41],0.9076209097018316
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,20473,289,1.42 [1.12-1.80],0.003599996804436
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,18831,76,1.48 [0.94-2.31],0.0874255631638038
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,18981,226,1.22 [0.90-1.66],0.1981863353305704
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,20467,283,1.43 [1.13-1.82],0.0031747321206247
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",18966,211,1.60 [1.26-2.03],9.94433860416895e-05
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,20490,105,1.37 [0.91-2.06],0.1326628690850758
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,17697,71,1.34 [0.81-2.22],0.2573097418210286
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,18705,4082,1.19 [1.10-1.28],4.975929150851206e-06
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,17502,2879,1.14 [1.05-1.25],0.0032822198884456
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,17690,64,1.50 [0.92-2.43],0.1010698913929449
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,18048,122,0.55 [0.30-1.03],0.0625948221556566
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,18046,120,1.24 [0.82-1.89],0.3053720472128897
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,20334,56,0.95 [0.45-2.00],0.8938577517817937
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",17992,66,1.55 [0.98-2.46],0.0623218142108657
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,15362,739,1.10 [0.92-1.32],0.3042025131226554
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",20407,128,0.91 [0.55-1.49],0.7001001521138172
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,18149,223,1.35 [1.02-1.80],0.0385224505011424
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,17447,5336,1.15 [1.08-1.24],2.572682433304977e-05
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,19620,85,1.44 [0.93-2.25],0.1051747497436067
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,17768,142,1.69 [1.26-2.25],0.0003826483542399
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,18014,388,1.10 [0.85-1.42],0.4700353990317536
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,19799,1873,1.18 [1.06-1.32],0.0030631118984773
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,17946,320,1.21 [0.93-1.59],0.1623039999247585
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,17674,48,1.53 [0.89-2.63],0.1258563466092395
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,17712,86,0.66 [0.33-1.35],0.2590467546047559
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,20233,27,0.68 [0.20-2.32],0.5332054266992163
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,15868,1245,1.15 [1.00-1.32],0.0431208091989299
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,15444,821,1.35 [1.17-1.57],5.8560225470662447e-05
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",20393,808,1.32 [1.14-1.54],0.0003019840523727
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,14659,36,0.94 [0.37-2.41],0.901012635441652
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),14692,69,1.42 [0.87-2.33],0.162217772358171
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,17850,224,1.47 [1.13-1.91],0.0040126068005781
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,15166,543,1.18 [0.95-1.45],0.129164675276972
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,17960,34,1.68 [0.92-3.08],0.0924977463139847
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,18367,441,1.33 [1.08-1.63],0.0065567690025034
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,18145,219,1.02 [0.71-1.46],0.916219332436584
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,15130,507,1.13 [0.91-1.41],0.2760426205047308
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,17682,56,0.91 [0.42-1.95],0.8008515154092113
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",17668,42,1.60 [0.92-2.80],0.096876010971549
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,19614,79,1.80 [1.26-2.56],0.0012411185618989
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,20266,731,1.30 [1.11-1.54],0.0013993979082562
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,19872,337,1.32 [1.04-1.67],0.0236264521197354
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",20446,255,1.52 [1.20-1.92],0.000431274452018
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,16229,1606,1.25 [1.12-1.40],0.0001111539434291
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,14668,45,1.31 [0.66-2.58],0.4409464023033702
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,17693,67,1.15 [0.63-2.10],0.6483627689551559
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,14672,49,1.28 [0.69-2.36],0.4370596423828808
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),14661,38,2.13 [1.41-3.22],0.0003542443267175
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,19693,158,0.77 [0.47-1.26],0.3039872363756338
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,19671,136,1.61 [1.18-2.19],0.002722281104991
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,20484,74,0.94 [0.50-1.79],0.857633447014334
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",19202,1276,1.17 [1.02-1.34],0.0219678930636472
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,17683,57,0.75 [0.33-1.71],0.4930999343936109
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),14657,34,1.73 [0.99-3.01],0.0542616121970652
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,18446,520,1.03 [0.82-1.30],0.7866624587980442
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,16082,1459,1.32 [1.18-1.48],2.165265505750062e-06
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,20251,45,1.60 [0.94-2.71],0.0829941699478794
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,20499,55,1.73 [1.12-2.68],0.0139171912740242
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,17697,71,0.87 [0.43-1.75],0.6938717926812157
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",18456,830,1.26 [1.08-1.47],0.0039609050509923
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,17705,79,1.66 [1.13-2.44],0.0097479976075208
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,15663,1040,1.24 [1.08-1.42],0.0026587711627663
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,19607,72,0.90 [0.46-1.76],0.7522596526415615
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,17664,38,1.39 [0.71-2.74],0.3357663587232438
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,18023,97,1.10 [0.66-1.83],0.7141487373915392
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,18048,422,1.23 [0.98-1.54],0.0702586458470058
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,20372,166,1.01 [0.67-1.52],0.9724736817766346
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,18333,407,1.32 [1.07-1.65],0.0110601864428158
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,20454,252,1.49 [1.17-1.90],0.0010826494191001
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,20501,34,1.36 [0.66-2.80],0.4060681078831709
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,17757,131,1.23 [0.82-1.84],0.3142406161306944
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,16841,484,1.40 [1.16-1.69],0.0004755783277775
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,18027,401,1.25 [1.00-1.57],0.0545904953367948
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],17916,290,1.25 [0.95-1.64],0.1179468464915073
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",14649,26,0.70 [0.20-2.42],0.5721640097523251
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,16561,1938,1.28 [1.16-1.41],1.3673110968011918e-06
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,15001,378,1.35 [1.08-1.67],0.0073307982810466
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,20344,138,1.02 [0.65-1.60],0.9311857105672612
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",20448,38,1.09 [0.48-2.46],0.8384922882908923
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",18811,37,0.92 [0.37-2.27],0.8586391107808681
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,14680,57,1.73 [1.14-2.63],0.0106659634205688
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,18004,78,1.40 [0.88-2.22],0.1542076611799527
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,14885,262,1.57 [1.26-1.96],6.643245607592256e-05
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,17874,248,1.34 [1.02-1.76],0.0341767770082104
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,18110,184,1.62 [1.24-2.10],0.000355027850412
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,17997,71,1.57 [1.02-2.43],0.0422909322772431
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,16309,26,1.51 [0.74-3.11],0.2593099408723592
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",20502,35,1.37 [0.68-2.78],0.3799699156982294
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,18077,451,1.38 [1.13-1.68],0.001245970946571
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sj¬ögren],20223,17,1.48 [0.57-3.81],0.422127949728571
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,19579,1953,1.22 [1.10-1.35],0.0002586581952661
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",17717,91,1.39 [0.91-2.14],0.1312611191809962
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,18343,417,1.25 [1.00-1.56],0.050393855354631
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,19589,171,0.96 [0.63-1.46],0.8621293054070145
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,18043,117,1.14 [0.73-1.79],0.5648157040782045
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,19030,1104,1.17 [1.01-1.35],0.0375993729957631
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,18609,683,1.20 [1.01-1.44],0.0427105172705828
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],17659,33,1.24 [0.55-2.79],0.6106205906708402
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,20243,37,1.75 [1.00-3.06],0.049199718001096
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,17736,110,1.02 [0.62-1.69],0.9248959616158986
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,17645,19,1.95 [1.07-3.56],0.0294038636285789
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),14675,52,1.70 [1.03-2.79],0.036422726794738
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Acute renal failure,19749,1537,1.51 [1.36-1.66],8.46706676806586e-16
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,20113,338,1.03 [0.77-1.36],0.8565099486751588
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,19897,122,0.88 [0.52-1.48],0.6308657609884033
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,19370,1158,1.67 [1.51-1.85],2.3928978604278501e-23
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,20306,49,2.64 [2.04-3.42],2.139340311769119e-13
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,20304,299,1.24 [0.95-1.61],0.1102507066054641
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Cystitis,18101,178,1.50 [1.12-2.00],0.0062147769048958
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Dialysis,18280,68,2.59 [2.04-3.29],4.811752273402827e-15
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,19432,2837,1.02 [0.93-1.13],0.6413584010251314
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,18547,4754,1.18 [1.10-1.27],3.240637119978117e-06
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,20332,75,2.28 [1.74-2.98],2.1508185914522603e-09
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Hydrocele,16770,175,1.17 [0.82-1.67],0.3884586544107613
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,18278,293,1.32 [1.02-1.71],0.0327025629092848
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,18824,2229,1.05 [0.94-1.17],0.4246195241533163
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),16794,199,1.13 [0.79-1.60],0.5078023492299795
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,17985,62,0.93 [0.45-1.90],0.8436524438436368
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,16694,99,0.94 [0.54-1.65],0.8297695929714034
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",20506,54,1.83 [1.21-2.78],0.0045451493676986
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",20507,46,1.57 [0.90-2.73],0.1093392109942761
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,19808,1885,1.22 [1.10-1.36],0.000273501298394
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,18747,824,1.08 [0.90-1.29],0.4102754686412754
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,20455,450,1.30 [1.06-1.60],0.0117511395274179
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,16860,265,1.01 [0.73-1.41],0.934727539855319
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,16838,243,1.27 [0.95-1.69],0.1003475371921315
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,16789,194,0.81 [0.53-1.25],0.3402234649348858
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,20501,41,1.24 [0.61-2.52],0.5525875086135106
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,19182,1259,1.33 [1.18-1.50],4.6657486426933804e-06
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,18314,329,1.32 [1.03-1.68],0.0252436004804237
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,20153,148,1.33 [0.93-1.90],0.1187371788937146
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,20313,56,1.77 [1.14-2.73],0.0101618220346105
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",16821,226,1.30 [0.98-1.73],0.0684607820621582
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,20294,2309,1.48 [1.36-1.61],1.951878473091434e-20
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",18040,55,1.95 [1.36-2.81],0.000286736368117
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,18331,119,1.87 [1.42-2.45],6.665109256678329e-06
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,19838,63,0.55 [0.23-1.30],0.1751744951449271
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Urethral stricture,18176,253,0.88 [0.61-1.26],0.4800983648971967
USP28,Ubiquitin carboxyl-terminal hydrolase 28,Chapter XIV Diseases of the genitourinary system,Urolithiasis,20216,441,0.92 [0.70-1.20],0.5268216554705625
